InsidersTradesSigma
Browse the complete record of transactions filed by Fontenot Jason D., Vice-Président, Directeur Scientifique. Officer active across 1 company, notably Sangamo Therapeutics, INC. Cumulatively, 2 reports have been published. History available since 25 February 2022. The latest transaction was filed on 25 April 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Jason D. Fontenot is the SVP and Chief Scientific Officer at SANGAMO THERAPEUTICS, INC. He is responsible for leading scientific initiatives and research within the company. His role is essential for ensuring innovation and the development of new products.